Abstract:The 8th edition TNM (TNM8) includes extra-nodal extension (ENE) for non-viral head and neck cancer. The prognostic value of ENE has not been emphasized in nasopharyngeal carcinoma (NPC). We evaluated the prognostic value of various grades of radiologic ENE (rENE) and their potential role in refining the N classification for NPC. All cN+ NPC patients (pts) treated with IMRT in our institution between 2005 and 2011 were included. Pre-treatment MRIs were reviewed by a specialized neuroradiologist. rENE was defined as a lymph node (LN) with irregular borders with (high-grade, HG) or without (low-grade, LG) adjacent structure invasion. If ≥2 LNs abutted together with rENE (loss of internodal fat plane) but without adjacent structure invasion, it was termed inter-mediate grade rENE (IG-rENE). Distant metastases free survival (DMFS), regional relapse free survival (RRFS), and overall survival (OS) were compared among rENE grades vs. cN+ without rENE (No-rENE). Multivariable analyses (MVA) confirmed the incremental prognostic value of the various grades of rENE. Refined N classification incorporating rENE grades was compared with TNM8 using Akaike information criterion (AIC) and Harrell’s concordance index (c-Index). A total of 1390 of 1616 (86%) NPC were cN+, in whom rENE was detected in 826 (59%) pts: 256 (18.4%) LG-rENE, 487 (35%) IG-rENE, and 83 (6%) HG-rENE. Median follow-up was 53 months. Actuarial rates of 5-year DMFS and OS decreased with higher grade of rENE (No-/LG-/IG-/HG-rENE): 88%/82%/74%/56% (p<0.001), 87%/81%/77%/60% (p<0.001), respectively. MVA (adjusted for age, gender, T, N, chemotherapy, LDH) confirmed that IG-rENE and HG-rENE had increased HRs for DM (HR: 1.97 and 3.00, p<0.001 and <0.001) and death (HR: 1.69 and 2.45, p=0.002 and <0.001), while LG-rENE was not prognostic (DMFS: HR=1.280, p=0.224; OS: HR=1.249, p=0.259). 5-year RRFS rates differed with rENE grades (96%/91%/93/91%, p=0.042) but was non-prognostic in MVA (p=0.286). N2 with No/LG-rENE had similar DMFS (87% vs. 85%, p=0.600) and OS (86% vs. 83%, p=0.630) vs N1 with No/LG pts. N2 with IG-rENE had similar DMFS (69% vs. 65%, p=0.509) and OS (71% vs. 71%, p=0.672) compared to N3 with No-/LG-rENE; HG-rENE pts had the most detrimental DMFS compared to the other groups (all p<0.05). We propose a refined N for future TNM to include IG-rENE and HG-rENE: New N1: N1 or N2_No/LG-rENE; New N2: N1_IG-rENE; New N3: N3 or N2_IG-rENE or any N_HG-rENE. Compared to the TNM8 N, the new N classification had a lower AIC and higher c-index for DMFS (AIC: 3809.6 vs 3830.9; c-index: 0.700 vs. 0.677) and OS (AIC: 3693.8 vs. 3705.9; c-index: 0.735 vs. 0.725). IG- and HG-rENE are independently prognostic for DMFS and OS in NPC. Compared to the TNM8 N classification, an N classification incorporating IG- and HG-rENE improves prognostication of risk of DM and death.

The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2N1 nasopharyngeal carcinoma: a multicenter retrospective study

The Role of Radiologic Extranodal Extension in Predicting Prognosis and Chemotherapy Benefit for T1-2 N1 Nasopharyngeal Carcinoma: A Multicenter Retrospective Study.

Prognostic Value of Radiologic Extranodal Extension and Its Potential Role in Future N Classification for Nasopharyngeal Carcinoma.

Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort

High-grade Radiologic Extra-nodal Extension Predicts Distant Metastasis in Stage II Nasopharyngeal Carcinoma

Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems

The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis

Prognostic Value of Radiologic Extra-nodal Extension and Its Potential to Refine the N Classification for Nasopharyngeal Carcinoma

Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation

Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy

Neoadjuvant Chemotherapy And Prognostic Subgroups Defined By Survival Benefit In Patients With Locoregionally Advanced Nasopharyngeal Carcinoma.

Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors

Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma

Role of Chemoradiotherapy in Intermediate Prognosis Nasopharyngeal Carcinoma

Exploration of the Value of Concurrent Chemotherapy for T2N1 Nasopharyngeal Carcinoma under Intensity Modulated Radiotherapy Mode

Effect of Perioperative Medical Therapy on Prognosis in Recurrent Nasopharyngeal Carcinoma: A Comparative Effectiveness Research.

Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: Defining High-Risk Patients Who May Benefit Before Concurrent Chemotherapy Combined with Intensity-Modulated Radiotherapy.

Can Neoadjuvant Chemotherapy Improve Survival in Stage T3-4N1 Nasopharyngeal Carcinoma? A Propensity Matched Analysis.

Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma

Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China